S
Southeastern Retina Associates | Knoxville, TN
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ranibizumab
Lampalizumab
bevacizumab
Serine
Fenofibrate
Triamcinolone Acetonide
Pegaptanib
ranibizumab
Avastin®
Parent organization
This site is a part of Southeastern Retina Associates
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 12 total trials
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration
Active, not recruiting
Macular Neovascularization Secondary to Age-Related Macular Degeneration
Biological: 4D-150 IVT (3E10 vg/eye)
Biological: EYLEA® (aflibercept) Injection 2 mg (0.05mL)
Trial sponsors
4
E
N
T
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems